E907 5 (Opana ER 5 mg)
Generic Name: oxymorphone
Pill with imprint E907 5 is Pink, Eight-sided and has been identified as Opana ER 5 mg. It is supplied by Endo Pharmaceuticals Inc..
Opana ER is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Opana ER 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for E907 5
Opana ER
- Generic Name
- oxymorphone
- Imprint
- E907 5
- Strength
- 5 mg
- Color
- Pink
- Size
- 8.00 mm
- Shape
- Eight-sided
- Availability
- Prescription only
- Drug Class
- Narcotic analgesics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Endo Pharmaceuticals Inc.
- National Drug Code (NDC)
- 63481-0907
- Inactive Ingredients
-
hypromelloses,
methylparaben,
sodium stearyl fumarate,
titanium dioxide,
triacetin,
polyethylene glycol,
polysorbate 80,
ferric oxide red
Note: Inactive ingredients may vary.
Submitted by: Drugs.com
More about Opana ER (oxymorphone)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- 85 Reviews
- Drug class: narcotic analgesics
- FDA Alerts (2)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.